Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Topical Cidofovir for Treatment of Resistant Viral Infections

Author(s):  McElhiney Linda F

Issue:  Sep/Oct 2006 - Dermatology
View All Articles in Issue

Abstract:  Cidofovir is a broad-spectrum antiviral agent with activity against several DNA viruses. An application to approve the use of topical cidofovir for acyclovir-resistant herpes virus infection was denied by the US Food and Drug Administration owing to the lack of phase III clinical trial data. The manufacturer stated that, as of 1997, no further controlled studies were planned or in progress to evaluate topical cidofovir in herpes simplex infections. It is unknown whether there are plans to conduct controlled studies of topical cidofovir for HPV or MVC infections. However, numerous case reports and published studies describe successful use of topical cidofovir to treat resistant and severe forms of viral infections such as molluscum contagiosum, condylomata acuminata, verruca vulgaris, herpes simplex virus infection, genital warts, and gingival infection with human papillomavirus. Because of the mutagenic properties of cidofovir, compounding the preparation is considered hazardous. Since most retail pharmacies

Related Keywords: Linda F. McElhiney, PharmD, RPh, cidofovir, antiviral agent, viral infections, topical preparations, antimicrobial resistance, molluscum contagiosum, condyloma acuminata, verruca vulgaris, genital warts, human papillomavirus, herpes simplex, CMV, cytomegalovirus retinitis, formulations

Related Categories: DERMATOLOGY, FORMULATIONS, LEGAL, WOUND CARE, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Topical Cidofovir for Treatment of Resistant Viral Infections McElhiney Linda F Sep/Oct 2006 324-328 Buy
Sensitization Therapy for Warts Kuntz Rachael Jul/Aug 2003 266 Buy
Basics of Compounding for the Treatment of Warts Allen Loyd V Jr Mar/Apr 2004 126 Buy
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr Jul/Aug 2001 310 Buy
Valacyclovir 50-mg/mL Oral Liquid Allen Loyd V Jr Nov/Dec 2006 461 Buy
Foscarnet Sodium 24-mg/mL Injection Allen Loyd V Jr Jul/Aug 2012 336 Buy
Cidofovir 0.2-mg/mL Intravitreous Injection Allen Loyd V Jr Nov/Dec 2009 554 Buy
Compounding Challenges for Immunocompromised Patients McElhiney Linda F Nov/Dec 2008 482-487 Buy
Quality Control Analytical Methods: End-preparation Assessments and Tests for Compounded Sterile Preparations McElhiney Linda F Jul/Aug 2013 307-311 Buy
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F Sep/Oct 2013 380-383 Buy